DEXCOM INC 8-K

What Happened
DexCom, Inc. announced its financial results for the quarter ended March 31, 2026 by issuing a press release on April 30, 2026 and furnished that release as Exhibit 99.1 to an 8-K (Item 2.02). The 8-K was signed by Jereme Sylvain, Executive Vice President and Chief Financial Officer, on April 30, 2026.

Key Details

• Company filed Form 8-K on April 30, 2026 under Item 2.02 (Results of Operations and Financial Condition).
• The press release reporting quarterly results for the period ended March 31, 2026 is furnished as Exhibit 99.1 to the 8-K.
• The filing was signed by Jereme Sylvain, EVP & Chief Financial Officer, on April 30, 2026.
• Exhibit list also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters
This 8-K makes DexCom’s latest quarterly earnings information public and directs investors to the full press release (Exhibit 99.1) for revenue, earnings, and any management commentary or guidance. Retail investors should review the press release for the specific financial metrics and any forward-looking statements that could affect near-term stock performance.